These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19099539)

  • 1. The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer.
    Assinder SJ; Dong Q; Kovacevic Z; Richardson DR
    Biochem J; 2009 Jan; 417(2):411-21. PubMed ID: 19099539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN, more than the AKT pathway.
    Blanco-Aparicio C; Renner O; Leal JF; Carnero A
    Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological targeting of the integrated protein kinase B, phosphatase and tensin homolog deleted on chromosome 10, and transforming growth factor-beta pathways in prostate cancer.
    Assinder SJ; Dong Q; Mangs H; Richardson DR
    Mol Pharmacol; 2009 Mar; 75(3):429-36. PubMed ID: 19052170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of transcript signatures of the phosphatidylinositol-3 kinase/protein kinase B signal-transduction pathway in prostate cancer.
    Hellwinkel OJ; Rogmann JP; Asong LE; Luebke AM; Eichelberg C; Ahyai S; Isbarn H; Graefen M; Huland H; Schlomm T
    BJU Int; 2008 Jun; 101(11):1454-60. PubMed ID: 18336616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of colorectal cancer.
    Saif MW; Chu E
    Cancer J; 2010; 16(3):196-201. PubMed ID: 20526096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.
    Dixon KM; Lui GY; Kovacevic Z; Zhang D; Yao M; Chen Z; Dong Q; Assinder SJ; Richardson DR
    Br J Cancer; 2013 Feb; 108(2):409-19. PubMed ID: 23287991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
    Lee DH; Szczepanski MJ; Lee YJ
    J Cell Biochem; 2009 Apr; 106(6):1113-22. PubMed ID: 19229860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PTEN/PI3K pathway in endothelial cells.
    Suzuki A; Hamada K; Sasaki T; Mak TW; Nakano T
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):172-6. PubMed ID: 17371230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the EGFR and the PKB pathway in cancer.
    Klein S; Levitzki A
    Curr Opin Cell Biol; 2009 Apr; 21(2):185-93. PubMed ID: 19216065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myostatin induces p300 degradation to silence cyclin D1 expression through the PI3K/PTEN/Akt pathway.
    Ji M; Zhang Q; Ye J; Wang X; Yang W; Zhu D
    Cell Signal; 2008 Aug; 20(8):1452-8. PubMed ID: 18472397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac regulation by phosphoinositide 3-kinases and PTEN.
    Oudit GY; Penninger JM
    Cardiovasc Res; 2009 May; 82(2):250-60. PubMed ID: 19147653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein phosphatase PP2A-B' subunit Widerborst is a negative regulator of cytoplasmic activated Akt and lipid metabolism in Drosophila.
    Vereshchagina N; Ramel MC; Bitoun E; Wilson C
    J Cell Sci; 2008 Oct; 121(Pt 20):3383-92. PubMed ID: 18827008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises.
    Yap TA; Garrett MD; Walton MI; Raynaud F; de Bono JS; Workman P
    Curr Opin Pharmacol; 2008 Aug; 8(4):393-412. PubMed ID: 18721898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discovery approaches targeting the PI3K/Akt pathway in cancer.
    Garcia-Echeverria C; Sellers WR
    Oncogene; 2008 Sep; 27(41):5511-26. PubMed ID: 18794885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PTEN-PI3K pathway: of feedbacks and cross-talks.
    Carracedo A; Pandolfi PP
    Oncogene; 2008 Sep; 27(41):5527-41. PubMed ID: 18794886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
    Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K
    Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN mutation: many birds with one stone in tumorigenesis.
    Liu W; Zhou Y; Reske SN; Shen C
    Anticancer Res; 2008; 28(6A):3613-9. PubMed ID: 19189642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in the PI3K pathway in prostate cancer.
    Sun X; Huang J; Homma T; Kita D; Klocker H; Schafer G; Boyle P; Ohgaki H
    Anticancer Res; 2009 May; 29(5):1739-43. PubMed ID: 19443396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
    Cakir M; Grossman AB
    Expert Opin Ther Targets; 2009 Sep; 13(9):1121-34. PubMed ID: 19637976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
    Chung S; Furihata M; Tamura K; Uemura M; Daigo Y; Nasu Y; Miki T; Shuin T; Fujioka T; Nakamura Y; Nakagawa H
    Oncogene; 2009 Aug; 28(32):2849-59. PubMed ID: 19483721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.